Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.
about
Mitochondria, cholesterol and cancer cell metabolismHER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interactionComparative analysis of NRF2-responsive gene expression in AcPC-1 pancreatic cancer cell lineAlisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cellsThe complexity of the Nrf2 pathway: beyond the antioxidant responseCytoprotection "gone astray": Nrf2 and its role in cancerInhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabineMechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cellsSoluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxificationBrusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells.Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2The complex landscape of pancreatic cancer metabolismEpigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancerThe role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines.Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma.Contribution of environment and genetics to pancreatic cancer susceptibilityQuantitative evaluation of aldo-keto reductase expression in hepatocellular carcinoma (HCC) cell lines.Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.Benefits and risks of the hormetic effects of dietary isothiocyanates on cancer prevention.miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.Keap1 expression has independent prognostic value in pancreatic adenocarcinomasMolecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAGRegulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species.NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesisNRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction.Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination.Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA DamageThe emerging role of the Nrf2-Keap1 signaling pathway in cancerNrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosisEsculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1.Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.
P2860
Q26741708-4B808C5E-A029-4015-B7A2-DA4DC119CA1FQ28383407-211A39A0-A365-4081-A5D1-63B7577DA27CQ28384407-B93BF10F-457D-4C5C-8F72-741A5B8F7200Q28386389-E6DD7D0C-AFAC-4A6F-B4D4-FCA8AAF4A955Q28389296-FFEBD40A-E67F-421C-8E7B-4659C44D267DQ28393784-03FDFEA2-1285-4CCC-BEAA-E136B448DE5DQ28396251-67CB9226-283F-4C56-97EB-3E00FDA65736Q28485201-B1380979-3F67-4E26-AB02-20BAF1C3BB6CQ28822225-5FEF19CA-A93B-4E20-A1EE-1CEA7AFD2F5BQ30614574-B8CAF0DD-AFC8-412C-B6AF-273EC4F096EFQ31057778-71EF943D-7572-4D0B-A000-4F30AAF2998BQ33688129-C9009A87-FCEA-4760-A809-0AC99CFF022EQ33827703-98D4F6B6-F814-48AB-B78B-3A9B0E3B195EQ34633152-9A557BD2-D2BF-4BA6-9082-56A89B0BEEC3Q35024476-C0ADDA41-C909-4D68-B919-EBEE825A921FQ35080411-2F36B8AE-247D-401A-8700-636BF2EB47F7Q35126601-B09C22DF-A1B9-490A-8DDB-0D0AC421742DQ35171770-561D60AC-C54F-4A5A-A3C4-5DE9274BCCC8Q35194850-CB639B1F-5ACD-4688-9795-2C6B3BAF2AAEQ35532384-B44EF533-FE85-4F43-9019-D4048BB4F767Q35562532-33DBD727-3535-4172-9AD8-A71230CAA6B6Q35576302-9B13E030-505F-4B0C-A0D4-6B51107B389EQ35659640-185BA1D4-65B5-462E-8576-7166C7631C4AQ35726483-72C6C8E6-CAA8-45C6-A993-5CAB79705780Q35936030-94AC2B10-2B07-4FA0-9567-502517DEAD7CQ35979667-C40D403B-68E1-4467-A33E-1DF938612311Q36162095-72FC3A93-E796-4855-9AB5-BF25811714A3Q36349182-72A716A5-4901-47E5-AE95-BD00D1F8714BQ36387554-E3CD0AE6-EEF0-4433-A5D5-3A32AB70AD02Q36536562-18F9E488-7511-4DA4-9E0F-C2215C495593Q36678635-7FEDE005-0946-4C08-AEF6-2EB1D73AFC21Q36745578-74F58DA3-705B-49E4-B79D-7D0C4E410630Q36962967-16DE2D84-2C5B-4369-85EB-E086CF47F56EQ37134317-4B59F043-4A1B-44D7-86C4-A7F52351518CQ37271797-2E3C6CBB-9A37-4313-A8E7-255A69AC323DQ38626095-23ACA83D-3278-48D3-AFB1-29B8B176CDA8Q38739818-F7AD6341-40AB-4987-A452-D92FE2A0E019Q38783129-A1E2FD82-07B0-4E04-A54D-52621344AF45Q38869922-788FB0D5-5430-4D36-A0EF-B126A94A3A5BQ38906721-3F90C625-EA33-4BB5-A396-A681A35E912D
P2860
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@ast
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@en
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@nl
type
label
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@ast
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@en
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@nl
prefLabel
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@ast
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@en
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Nrf2 is overexpressed in pancr ...... ell proliferation and therapy.
@en
P2093
Adam Lister
B Kevin Park
Bryony Lloyd
Chris E Goldring
Fiona Campbell
Ian M Copple
Neil R Kitteringham
Samantha Williams
Taoufik Nedjadi
P2860
P2888
P356
10.1186/1476-4598-10-37
P577
2011-04-13T00:00:00Z
P5875
P6179
1013400177